SeeThruEquity Announces Company Lineup for Fall 2012 Smallcap and Microcap Investor Conference on October 2 and 3, 2012
September 24 2012 - 11:47AM
Business Wire
SeeThruEquity, a leading investment research and corporate
access firm focused on public smallcap and microcap companies, is
hosting its Fall Smallcap and Microcap Investor Conference on
October 2 and 3, 2012 at the Cornell Club in midtown Manhattan.
Registration will begin at 7:45AM on October 2 and will run from
8am to 5pm on October 2 and 12pm to 5pm on October 3.
Senior management from a select group of companies will make
presentations about their respective businesses to an elite group
of institutional and retail investors, equity analysts and industry
professionals. 1-on-1 meetings between qualified investors and the
presenting companies will also be arranged by appointment.
Presenting companies to include:
Applied DNA Sciences Inc. OTCBB: APDN Bovie Medical Corp
NYSE: BVX China Digital TV Holding Co
NYSE: STV
diaDexus, Inc
OTC: DDXS
International Stem Cell Corp
OTC: ISCO
Inuvo, Inc.
NYSE: INUV
Mac-Gray Corp
NYSE: TUC
Perma-Fix Environmental Services Inc.
NASDAQ: PESI
Quadrant 4 Systems Corp
OTC: QFOR
SoundBite Communications, Inc. NASDAQ: SDBT The Cash Store
Financial Services, Inc.
NYSE: CSFS
Qualified investors and equity research analysts may attend the
conference without charge and other interested parties may join the
conference for a $149 fee. Please visit SeeThruEquity Fall
Conference Home Page for more information about the conference.
You may register for the conference by clicking SeeThruEquity
Fall Conference Attendee Registration.
About SeeThruEquity, LLC
SeeThruEquity, LLC is an investment research and corporate
access firm that produces high quality research reports on smallcap
and microcap companies with less than $1 billion in market
capitalization. The traditional Wall Street analyst establishment
has typically underserved these companies. We are unfettered by any
ties to investment banking or trading, and distribute our high
impact research as an approved firm for consensus estimates on
Thomson Reuters, CapitalIQ, FactSet, Zacks and StockTwits, as well
as to our own audience of investors from our corporate website.
Our philosophy is focused on delivering an unbiased, institutional quality research product
for such uncovered or undercovered companies to all levels of
investors in the investment community and at absolutely no charge
to the reader of the research or the company being covered. We seek
to build relationships between corporate issuers and institutional
and sophisticated investors via compelling investor conferences and
forums as well as non-deal road shows.
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Sep 2023 to Sep 2024